Table 3.

Differences in enrollment before and after the intervention.

	Prior to intervention Nov 9, 2015–Feb 29, 2016 (112 days)	After intervention Mar 1, 2016–June 24, 2016 (115 days)	P*
Screened patients, N	139	157
Eligible patients, N (% of patients screened)	25 (18)	15 (10)
Enrollment, N (% of patients eligible)
Enrolled patients	17 (68)	11 (73)	1.0
Initial consent by SDM, N (% enrolled)	14 (82)	7 (64)
Initial consent by self, N (% enrolled)	3 (18)	4 (36)
Non-enrolled patients†	8 (32)	4 (27)
Days to initial consent or decline, median, IQR
Days to initial consent by SDM	26.5 (14–41)	3 (3–6)	0.004
Days to initial consent by self	15 (2–30)	3 (2–6)	0.27
Days to decline for non-enrolled patients	12 (6.5–27)	1.5 (1–3.5)	0.026

SDM, surrogate decision maker; IQR, interquartile range.

^*P values were calculated with the Wilcoxon rank sum test for continuous variables and the Fisher exact test for categorical variables.

^†Patient/SDM declined or patient died/transferred during recruitment